Two Greek-American Investors Return to Greece to Raise €106M for Its First Life Sciences Fund
Founded by investors with backgrounds in Wall Street biotech research and healthcare finance, Kos aims to give European life sciences companies greater access to US industry expertise, capital, and networks.
